Compare Nabla vs PathAI

Both tools in AI Healthcare

Nabla

Ambient AI assistant for clinicians that converts patient conversations into structured notes, coding suggestions, and EHR-ready documentation.

0 upvotesbeginner

PathAI

AI-powered digital pathology platform that automates slide analysis, biomarker quantification, and drug development support for labs and biopharma.

0 upvotesadvanced
Pricing

Pricing Comparison

NablaNabla
Free Trial$0

Full feature access for a limited period

Pro$Custom/month

Full access, priority support, EHR integration

Enterprise$Custom

Multi-site deployment, dedicated success team

PathAIPathAI
Enterprise$Custom

Annual licensing, cloud infrastructure, algorithm modules

Biopharma$Custom

Companion diagnostic development, clinical trial services, data licensing

Features

Feature Comparison

NablaNabla
Ambient Conversation CaptureSpecialty-Specific SOAP NotesLive Transcript ViewReferral Letter GenerationPatient-Facing Visit SummaryMedical Coding SuggestionsCustom Dot PhrasesNote Formatting Customization40+ EHR IntegrationsNative Epic Integrationathenahealth IntegrationMultilingual Encounter SupportCustom Note InstructionsChrome Extension AvailabilityiOS and Android AppNo Audio Storage by DefaultSOC 2 Type 2 and ISO 27001 Certified
PathAIPathAI
AISight Digital Pathology PlatformWhole Slide Image ManagementAI Tumor Detection AlgorithmsBiomarker Quantification (PD-L1, HER2)MASH AI Assist (FDA and EMA Qualified)Companion Diagnostic DevelopmentPrecision Pathology Network AccessPLUTO Foundation ModelExplore Biomarker Discovery SuiteLIS IntegrationCase Management AutomationRemote Consultation and AnnotationGCP and GCLP Compliant Lab ServicesFDA-Cleared AISight Dx PlatformClinical Trial Patient StratificationReal-World Data MonetizationPathologist Network (450+ contributors)
Fit

Best For & Not For

NablaNabla
✅ Best For
Clinicians across primary care, psychiatry, emergency medicine, and 35+ other specialties who want a fast, easy-to-deploy AI scribe without a lengthy enterprise rollout. Individual physicians and small practices that want a free trial before committing, and larger health organizations looking for HIPAA-certified ambient documentation with native EHR integrations.
❌ Not For
Users who need advanced revenue cycle automation or pre-visit intelligence modules alongside basic documentation. Health systems that require on-premises deployment rather than a cloud-based SaaS solution.
PathAIPathAI
✅ Best For
Anatomic pathology laboratories at academic medical centers, reference labs, and health systems looking to digitize workflows and deploy AI-powered diagnostic algorithms. Biopharma companies developing companion diagnostics, conducting clinical trials, or seeking AI-assisted biomarker discovery using validated pathology datasets.
❌ Not For
Individual clinicians or small outpatient practices without pathology laboratory operations. Organizations seeking ambient documentation or clinical note generation rather than digital pathology image analysis and drug development tools.
Availability

Platform & Accessibility

NablaNabla
web-basedmobilechrome-extensionapi
PathAIPathAI
web-basedapi
Use & Audience

Tasks & Who It's For

Integrations

Integrations

NablaNabla
Other
EpicathenahealthOracle HealthNextgen
PathAIPathAI
Other
Quest Diagnostics LISLabcorp LISPaigeVisiopharm
Use Cases

Real-world Use Cases

NablaNabla
1
Dr. Mischa, a psychologist, reduced her weekend charting from 10 hours to 3 hours after adopting Nabla, freeing time for family while improving note accuracy with less re-editing.
2
An emergency physician at a high-volume urban ER uses Nabla to document 14 patients per shift and says she cannot imagine going back to manual charting after 14 years without it.
3
Dr. Rivera, a vascular surgeon, uses Nabla for complex 30-minute consultations and receives a fully structured note in under 10 seconds that captures every problem and the complete care plan.
PathAIPathAI
1
A reference lab pathologist reviews 80 cases per day with AISight's AI-flagged priority queue, focusing attention on the highest-risk slides first and reducing average sign-out time by 35%.
2
A biopharma data scientist uses PathAI's Explore biomarker discovery suite to identify a novel spatial biomarker in a pancreatic cancer dataset of 12,000 slides that predicts immunotherapy response, advancing a Phase 2 trial design.
3
Labcorp deploys AISight Dx across its US pathology network after its expanded PathAI partnership, enabling digital workflows for case management, slide review, and AI-assisted annotation at scale.
Keep Exploring

Similar Comparisons